Chemical Compound Review:
Amphotericin B sodium desoxycholate sodium; (1R,3S,5R,6R,9R,11R,15S,16R,17 R...
Synonyms:
- Comparative antifungal activities and plasma pharmacokinetics of micafungin (FK463) against disseminated candidiasis and invasive pulmonary aspergillosis in persistently neutropenic rabbits. Petraitis, V., Petraitiene, R., Groll, A.H., Roussillon, K., Hemmings, M., Lyman, C.A., Sein, T., Bacher, J., Bekersky, I., Walsh, T.J. Antimicrob. Agents Chemother. (2002)
- Treatment of leishmaniasis in HIV-positive patients. Laguna, F. Ann. Trop. Med. Parasitol. (2003)
- Dose-dependent pharmacokinetics of amphotericin B lipid complex in rabbits. Walsh, T.J., Jackson, A.J., Lee, J.W., Amantea, M., Sein, T., Bacher, J., Zech, L. Antimicrob. Agents Chemother. (2000)
- Comparative pharmacokinetics, tissue distributions, and effects on renal function of novel polymeric formulations of amphotericin B and amphotericin B-deoxycholate in rats. Echevarría, I., Barturen, C., Renedo, M.J., Trocóniz, I.F., Dios-Viéitez, M.C. Antimicrob. Agents Chemother. (2000)
- Tissue concentrations and bioactivity of amphotericin B in cancer patients treated with amphotericin B-deoxycholate. Collette, N., van der Auwera, P., Lopez, A.P., Heymans, C., Meunier, F. Antimicrob. Agents Chemother. (1989)
- Heat-induced reformulation of amphotericin B-deoxycholate favours drug uptake by the macrophage-like cell line J774. Chéron, M., Petit, C., Bolard, J., Gaboriau, F. J. Antimicrob. Chemother. (2003)
- In-vitro effects of liposome-encapsulated amphotericin B (AmBisome) and amphotericin B-deoxycholate (Fungizone) on the phagocytic and candidacidal function of human polymorphonuclear leucocytes. Pallister, C.J., Johnson, E.M., Warnock, D.W., Elliot, P.J., Reeves, D.F. J. Antimicrob. Chemother. (1992)
- In-vitro effects of cilofungin (LY121019), amphotericin B and amphotericin B-deoxycholate on human polymorphonuclear leucocytes. Van der Auwera, P., Meunier, F. J. Antimicrob. Chemother. (1989)
- Role of humoral mediators in, and influence of a liposomal formulation on, acute amphotericin B nephrotoxicity. Sabra, R., Zeinoun, N., Sharaf, L.H., Ghali, R., Beshara, G., Serhal, H. Pharmacol. Toxicol. (2001)
- The effect of amphotericin B-deoxycholate on proliferation and protein synthesis in human skin fibroblast cultures. Fujimoto, W.Y., Starman, B.J., Rowe, D.W. In vitro. (1978)
- Relationship of pharmacokinetics and drug distribution in tissue to increased safety of amphotericin B colloidal dispersion in dogs. Fielding, R.M., Singer, A.W., Wang, L.H., Babbar, S., Guo, L.S. Antimicrob. Agents Chemother. (1992)
- Animal models: usefulness for studies of fungal pathogenesis and drug efficacy in aspergillosis. Andriole, V.T., Miniter, P., George, D., Kordick, D., Patterson, T.F. Clin. Infect. Dis. (1992)
- Polydispersity of aggregates formed by the polyene antibiotic amphotericin B and deoxycholate. A spin label study. Lamy-Freund, M.T., Ferreira, V.F., Schreier, S. Biochim. Biophys. Acta (1989)